tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market

Insight Molecular Diagnostics (IMDX) Balance Sheet

Compare
429 Followers

Insight Molecular Diagnostics Balance Sheet

Insight Molecular Diagnostics's total assets for Q3 2025 were $43.94M, a decrease of -13.03% from the previous quarter. IMDX total liabilities were $53.13M for the fiscal quarter, a 7.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 35.08M$ 74.89M$ 100.09M$ 159.56M$ 55.42M
Total Liabilities
$ 47.35M$ 54.42M$ 60.50M$ 94.35M$ 21.94M
Total Equity Gross Minority
$ -12.27M$ 20.47M$ 39.59M$ 65.22M$ 33.48M
Other Metrics
Currency in USD

Insight Molecular Diagnostics Debt to Assets